LUGPA 2024 Enduring CME Program   

	Disclaimer: Participants who previously attended the live LUGPA 2024 CME Program and claimed CME are not eligible to claim CME credit for the corresponding enduring activity.

Access the course by logging into LUGPALearn with your single sign on.   

Course Description 

Adapted from a live program presented at the LUGPA 2024 Annual Meeting, this enduring activity brings ongoing access to essential updates and innovations in urologic care. Designed for practicing urologists and advanced practice providers, the program explores emerging technologies and evolving clinical strategies aimed at improving patient outcomes and streamlining care. Learners will evaluate current treatment modalities for urologic cancers, optimize protocols for prostate cancer monitoring, and implement best practices for bladder cancer therapy and overactive bladder care programs. Additional sessions highlight treatment pathways for BPH, the integration of robotics and other advanced technologies into urologic practice, and practical tools to reduce stress and mitigate provider burnout. 

Learning Objectives  

1. Evaluate the differences in therapies used to treat urologic cancers. 
2. Analyze the optimal way to monitor and test for the treatment prostate cancer. 
3. Adopt and develop best practices in the administration of bladder cancer therapies. 
4. Identify the clinical and operational components to establish a successful over active bladder care programs. 
5. Describe the various treatment options and outcomes for BPH. 
6. Review and appraise the use of robotics and other technologies in a urology practice. 
7. Adopt new behaviors to manage stress and burnout. 

Accreditation and Designation Statement  

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and the LUPGA.  

PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians. PeerPoint Medical Education Institute designates the enduring format for this educational activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activities.  

The enduring approval period is: July 14, 2025 – July 14, 2028 

Accreditation and Designation Statements and Disclosure Report.pdf 

Recorded Sessions Include:  
 
Making Sense of Advanced Technologies to Integrate into your OAB Program. 
Moderator: Kari Bailey, MD 
Panelists: David Sussman, DO 
Neil Kocher, MD 
 
SURE (Steerable Ureteroscopic Renal Evacuation) procedure for the treatment and elimination of kidney stones. 
Presenter: Tom Mueller, MD 
 
Focal Therapy: Killing Cancer Not the Prostate. 
Presenter: Arvin George, MD 
 
What’s New in Robotic Surgery? 
Presenter: Ronney Abaza, MD 
 
Five Things Urologists Need to Know Now about Bladder and Kidney Cancer in 2025. 
Presenter: Tom Jayram, MD 
 
Cultivating Wellness & Resilience in Your Individual Life and Your Practice 
Presenter: Phillip M. Pierorazio, MD 

Incorporating New Approaches for Evaluating, Diagnosing and Treating BPH. 
Moderator: Kevin McVary, MD 
Panelists: Kevin Zorn, MD 
Timothy McClure, MD 
 
Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments. 
Presenter: Scott Eggener, MD 
 
Integrating New Technologies into Everyday Practice Management 
Moderator: Neal Patel, MD 
Panelists: 
Candice Sonko 
Mark Thompson 
Alicia Davis, RN, BSN